Cite

HARVARD Citation

    Takeyasu, Y. et al. (2017). Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report. Clinical case reports. 5 (12), pp. 2047-2050. [Online]. 
  
Back to record